
Hologic Investor Relations Material
Latest events

Q2 2025
Hologic
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Hologic Inc
Access all reports
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. The company offers technologies for mammography, 3D breast tomosynthesis (MammoSite(TM)), and FDA-cleared digital breast tomosynthesis (3D mammography); gynecologic imaging systems; and instruments for gynecology procedures; as well as software for diagnostic oncology centers and breast imaging. It also provides surgical services to support pre-, intra-, and postoperative care by surgeons or oncologists; preoperative planning tools for tumor management; and pathology review tools. In addition, the company offers facial aesthetics products comprising of injection devices designed to enhance aesthetics in patients undergoing anti-aging or cosmetic treatments such as neuromodulators that are used to smooth wrinkles and fine lines around the eyes.
Key slides for Hologic Inc


Q2 2025
Hologic Inc


43rd Annual J.P. Morgan Healthcare Conference 2025
Hologic Inc
Latest articles
)
Upcoming IPOs to Watch in 2025
Potential IPOs in 2025 include prominent names like Shein, Databricks, Klarna, eToro, and Figma, to name a few. Let's take a closer look.
23 May 2025
)
Figma: Collaborative Design Tool Ready for IPO
Figma, the popular design platform, is preparing for a potential IPO in 2025 as it continues to reshape the future of collaborative design.
22 May 2025
)
Companies That Had Their IPO in 2024: Momentum Increasing
2024 marked a steady year for IPOs, driven by strong markets, AI momentum, and high-profile listings across industries and regions.
22 May 2025
Ticker symbol
HOLX
Country
🇺🇸 United States